Regression of cerebral lesions after cessation of oral contraceptives.
D000328:Adult; D001932:Brain Neoplasms / Q000175:diagnosis; D002533:Cerebral Angiography; D002561:Cerebrovascular Disorders / Q000139:chemically induced* / Q000175:diagnosis; D003276:Contraceptives, Oral / Q000009:adverse effects*; D003937:Diagnosis, Differential; D004569:Electroencephalography; D005158:Facial Paralysis / Q000209:etiology; D005260:Female; D006261:Headache / Q000209:etiology; D006801:Humans; D008656:Mestranol / Q000009:adverse effects*; D009461:Neurologic Manifestations; D009640:Norethindrone / Q000009:adverse effects*; D010211:Papilledema / Q000209:etiology; D010243:Paralysis / Q000209:etiology; D011247:Pregnancy; D011877:Radionuclide Imaging; D012018:Reflex
D003276:Contraceptives, Oral; D008656:Mestranol; D009640:Norethindrone